Former Bristol-Myers Squibb employee pleads guilty to theft of trade secrets

9 November 2010

US Attorney for the Northern District of New York Richard Hartunian says that a former employee of US drug major Bristol-Myers Squibb (NYSE: BMY) has pleaded guilty to theft of the company’s trade secrets.

Shalin Jhaveri, who holds a PhD, and was employed at the time of his arrest in February 2010 as a technical operations associate in B-MS’ management training program. During his employment, Mr Jhaveri stole trade secrets from the drugmaker and devised a plan to convert them to his own use. At the time of his arrest, he was meeting in a Syracuse, New York hotel room with an individual he believed was an investor willing to finance a business venture Mr Jhaveri planned to start in his native India. Jhaveri transferred B-MS trade secrets to this investor, an individual he knew was not employed by or associated with the company in any capacity.

As part of his plea, Mr Jhaveri admitted the following:

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical